BioPharma Dive

BioPharma Dive provides news and analysis for biotech and biopharmaceutical executives, covering clinical trials, drug discovery and development, pharma marketing, FDA approvals and regulations, and drug pricing. Topic tags include Pharma, Biotech, FDA, Clinical Trials, Deals, Drug Pricing and Gene Therapy.

Recent coverage spans Telix buying ITM to build what the site calls a radiopharmaceutical powerhouse, Beacon's eye gene therapy hitting its mark in a late-stage study, and Novo talking up drug launches to win back investors. A tracker feature follows biotech IPOs, including ADARx Pharmaceuticals, valued at around $1.8 billion at the midpoint of its offering, and a news roundup covers Ultragenyx pricing a Sanfilippo gene therapy at $4M. The title is published by Informa TechTarget alongside Healthcare Dive, MedTech Dive and PharmaVoice.